Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes.
D000818:Animals; D003602:Cytotoxicity, Immunologic; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D051379:Mice
D007376:Interleukin-2